Heart Type Fatty Acid Binding Protein Detection Reagent(H-FABP)
H-FABP Overview
H-FABP mainly exists in the cytoplasm of myocardial cells. It is a kind of cytoplasmic small molecular protein. When myocardial injury occurs, H-FABP can be rapidly released into the blood and quickly removed from the plasma through the kidney to return to normal; AMI began to rise 30 minutes after onset, peaked at 6-8 hours and returned to normal at 20 hours. The sensitivity of H-FABP in the diagnosis of early AMI is much higher than that of myo, CTN and CK-MB, and the specificity is higher than that of myo. It is more valuable for the early diagnosis of chest pain within 3 hours
H-FABP Performance index
| Detection range | sample size | Sample type | Test time |
| 2～120ng/mL | 60μl | Serum / plasma / whole blood | 15min |
H-FABP Clinical Significance
- Indicators for early diagnosis and reinfarction of acute myocardial infarction
- Assessment of myocardial infarction size
- Differential diagnosis and prognosis of acute coronary syndrome
- Effective index for evaluating the effect of myocardial reperfusion
- Severity and prognosis of heart failure
- Prognosis of pulmonary embolism
Clinical comparison of H-FABP
Company profile
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.
